Aurinia Pharmaceuticals (AUPH) Leases: 2020-2025
Historic Leases for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Sep 2025 value amounting to $78.8 million.
- Aurinia Pharmaceuticals' Leases fell 18.29% to $78.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.8 million, marking a year-over-year decrease of 18.29%. This contributed to the annual value of $92.1 million for FY2024, which is 15.31% down from last year.
- Latest data reveals that Aurinia Pharmaceuticals reported Leases of $78.8 million as of Q3 2025, which was down 5.27% from $83.2 million recorded in Q2 2025.
- In the past 5 years, Aurinia Pharmaceuticals' Leases registered a high of $117.4 million during Q2 2023, and its lowest value of $4.8 million during Q1 2023.
- Moreover, its 3-year median value for Leases was $96.5 million (2024), whereas its average is $89.8 million.
- In the last 5 years, Aurinia Pharmaceuticals' Leases surged by 2,212.03% in 2023 and then decreased by 18.29% in 2025.
- Aurinia Pharmaceuticals' Leases (Quarterly) stood at $5.4 million in 2021, then dropped by 8.84% to $4.9 million in 2022, then skyrocketed by 2,115.51% to $108.7 million in 2023, then fell by 15.31% to $92.1 million in 2024, then declined by 18.29% to $78.8 million in 2025.
- Its last three reported values are $78.8 million in Q3 2025, $83.2 million for Q2 2025, and $87.6 million during Q1 2025.